85-1562-76　Oxaliplatin 500mg　CAS No:61825-94-3,63121-00-6　O8102-01

特徴

• Oxaliplatin is a a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. It is typically used in combination with fluorouracil (5-FU) and leucovorin, known as FOLFOX, for the treatment of colorectal cancer. The leucovorin-modulated single-agent 5-FU regimens achieved a median overall survival of 15 months or less. Combination regimens of FOLFOX consistently lead to median survivals in the 15-20 month range.
• Synonyms:[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']platinum; (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum; (1R-trans)-1,2-Cyclohexanediamine Platinum Complex; Dacplat; Eloxatin; Elplat; Lipoxal; Oxalatoplatinum
• Molecular Formula:C8H14N2O4Pt
• Molecular Weight:397.29
• Purity:≥99%
• Appearance:White to off-white powder
• Elemental Analysis:Calculated:C: 24.19%H: 3.55%N: 7.05%
• Solubility:Soluble in water at 4mg/ml and DMSO at 20mg/ml; very slightly soluble in methanol; insoluble in ethanol.
• Storage and Stability:Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C.
• Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
• Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.